R. Kate Kelley, MD, University of California-San Francisco
Articles by R. Kate Kelley, MD, University of California-San Francisco

Cholangiocarcinoma: Potential Therapies Under Investigation
ByJohn L. Marshall, MD, The Ruesch Center for the Cure of GI Cancers,R. Kate Kelley, MD, University of California-San Francisco,Sameek Roychowdhury, MD, PhD, James Cancer Hospital & Solove Research Institute,Milind Javle, MD, The University of Texas MD Anderson Cancer Center An overview of various treatment opportunities under study that are looking at using novel techniques to help personalize treatment for patients with bile duct cancers.

IDH Targeting in Advanced Cholangiocarcinoma
ByJohn L. Marshall, MD, The Ruesch Center for the Cure of GI Cancers,R. Kate Kelley, MD, University of California-San Francisco,Sameek Roychowdhury, MD, PhD, James Cancer Hospital & Solove Research Institute,Milind Javle, MD, The University of Texas MD Anderson Cancer Center Considerations for treating appropriate patients with advanced cholangiocarcinoma with an IDH inhibitor.